The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted cycloalkyl aminoalcohols. A preferred specific N,N-disubstituted cycloalkyl aminoalcohol is the compound: ##STR1##

 
Web www.patentalert.com

< Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications

< Method of treating ovarian cancers with cadmium

> (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

> Genes associated with diseases of the kidney

~ 00098